|
||
Original Article |
Results in Embryonic Lethality: Characterization of the Kinase Dependence of Stress Responses of Enzyme-Deficient Embryonic Stem Cells
b Department of Genetic Technologies, Pfizer Central Research, Groton, Connecticut 06340
Department of Respiratory, Allergy, Immunology, Inflammation, and Infectious Diseases, Central Research, Pfizer, Inc., Groton, CT 06340.860-715-2467860-441-5483
christopher_a_gabel{at}groton.pfizer.com
The mitogen-activated protein (MAP) kinase p38 is a key component of stress response pathways and the target of cytokine-suppressing antiinflammatory drugs (CSAIDs). A genetic approach was employed to inactivate the gene encoding one p38 isoform, p38
. Mice null for the p38
allele die during embryonic development. p38
1/– embryonic stem (ES) cells grown in the presence of high neomycin concentrations demonstrated conversion of the wild-type allele to a targeted allele. p38
–/– ES cells lacked p38
protein and failed to activate MAP kinase–activated protein (MAPKAP) kinase 2 in response to chemical stress inducers. In contrast, p38
1/+ ES cells and primary embryonic fibroblasts responded to stress stimuli and phosphorylated p38
, and activated MAPKAP kinase 2. After in vitro differentiation, both wild-type and p38
–/– ES cells yielded cells that expressed the interleukin 1 receptor (IL-1R). p38
1/+ but not p38
–/– IL-1R–positive cells responded to IL-1 activation to produce IL-6. Comparison of chemical-induced apoptosis processes revealed no significant difference between the p38
1/+ and p38
–/– ES cells. Therefore, these studies demonstrate that p38
is a major upstream activator of MAPKAP kinase 2 and a key component of the IL-1 signaling pathway. However, p38
does not serve an indispensable role in apoptosis.
Key Words: inflammation cytokines mitogen-activated protein kinase signaling cytokine-suppressing antiinflammatory drug
© 2000 The Rockefeller University Press
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
| TABLE OF CONTENTS |
|